IBDase
Mucosal protease and their inhibitors in inflammatory bowel disease: From etiopathogenetic insight to innovative therapy
7th European Mucosal Immunology Group Meeting
September/2010/
7th European Mucosal Immunology Group
Meeting
Amsterdam, The Netherlands
September 29 - October 2, 2010
Amsterdam, The Netherlands
September 29 - October 2, 2010
14th International Congress of Immunology
August/2010/
14th International Congress of
Immunology
Kobe, Japan (Kansai Region)
August 22-27, 2010
Kobe, Japan (Kansai Region)
August 22-27, 2010
Gordon Research Conference "Proteolytic Enzymes & their Inhibitors"
May/2010/
Gordon Research Conference "Proteolytic
Enzymes & their Inhibitors"
Lucca (Barga), Italy
May 2-7, 2010
IBDase partner UBERN will present concepts and results of miRNA studies conducted within IBDase.
Lucca (Barga), Italy
May 2-7, 2010
IBDase partner UBERN will present concepts and results of miRNA studies conducted within IBDase.
Digestive Disease Week (DDW) 2010
May/2010/
5th International Meeting on IBD
April/2010/
5th International Meeting on Inflammatory
Bowel Diseases
Capri, Italy
April 8-10, 2010
Several members of the IBDase Consortium will participate in this event and present their latest research.
Capri, Italy
April 8-10, 2010
Several members of the IBDase Consortium will participate in this event and present their latest research.
USGEB Annual Meeting
February/2010/
USGEB (Union of Swiss societies working
in experimental biology) Annual Meeting
Lugano, Switzerland
February 11-12, 2010
IBDase members presented work titled 'Expression profile of proteases and their inhibitors in the intestinal mucosa of IBD animal models'
Lugano, Switzerland
February 11-12, 2010
IBDase members presented work titled 'Expression profile of proteases and their inhibitors in the intestinal mucosa of IBD animal models'
5th Congress of ECCO
February/2010/
5th Congress of ECCO (European Crohn's
and Colitis Organisation)
Prague, Czech Republic
February 25-27, 2010
Work by the IBDase Consortium will be presented at this conference.
Prague, Czech Republic
February 25-27, 2010
Work by the IBDase Consortium will be presented at this conference.
Swiss RNA Workshop
January/2010/
Swiss RNA Workshop
Bern, Switzerland
January 15, 2010
Partner UBERN presented results under the title 'miRNA expression and regulation in inflammatory bowel disease'
Bern, Switzerland
January 15, 2010
Partner UBERN presented results under the title 'miRNA expression and regulation in inflammatory bowel disease'
6th General Meeting of the International Proteolysis Society
October/2009/
6th General Meeting of the International
Proteolysis Society
Surfers Paradise, Australia
October 26-30, 2009
Several members of the IBDase consortium participated in this event. Camila Mendes (UBERN) presented project research results under the title 'Mucosal Proteases and their Inhibitors in Inflammatory Bowel Disease: microRNA and alternative splicing regulation'.
Surfers Paradise, Australia
October 26-30, 2009
Several members of the IBDase consortium participated in this event. Camila Mendes (UBERN) presented project research results under the title 'Mucosal Proteases and their Inhibitors in Inflammatory Bowel Disease: microRNA and alternative splicing regulation'.
2nd European Congress of Immunology
September/2009/
2nd EUROPEAN CONGRESS OF
IMMUNOLOGY
Berlin, Germany
September 13-16, 2009
Berlin, Germany
September 13-16, 2009
International Symposium on pediatric IBD
September/2009/
International Symposium on Pediatric
Inflammatory Bowel Disease
Paris, France
September 9-12, 2009
A member of the consortium presented ‘Expression profile of proteases and their inhibitors in the intestinal mucosa of IBD animal models’.
Paris, France
September 9-12, 2009
A member of the consortium presented ‘Expression profile of proteases and their inhibitors in the intestinal mucosa of IBD animal models’.
Sackler Symposium "Microbes and Health"
September/2009/
Sackler Symposium "Microbes and Health"
of the National Academy of Sciences
USA
Irvine, CA, USA
November 2-3, 2009
Partner UGOT participated in this conference and presented research conducted in IBDase.
Irvine, CA, USA
November 2-3, 2009
Partner UGOT participated in this conference and presented research conducted in IBDase.
International Congress of Mucosal Immunology
July/2009/
International Congress of Mucosal
Immunology
Boston Marriott Copley Place
Boston, Massachusetts, USA
July 5-9, 2009
Several members of the IBDase consortium participated at this conference.
Boston Marriott Copley Place
Boston, Massachusetts, USA
July 5-9, 2009
Several members of the IBDase consortium participated at this conference.
Gordon Research Conference "Cilia, Mucus and Mucociliary Interactions"
February/2009/
Gordon Research Conference "Cilia, Mucus
and Mucociliary Interactions"
Lucca, Italy
February 22-27, 2009
Partner UGOT participated in this conference and presented research conducted in IBDase.
Lucca, Italy
February 22-27, 2009
Partner UGOT participated in this conference and presented research conducted in IBDase.
Keystone symposium: Therapeutic Modulation of RNA using Oligonucleotides
February/2009/
Keystone symposium: Therapeutic
Modulation of RNA Using
Oligonucleotides
Fairmont Chateau Lake Louise, Canada
February 8-13, 2009
IBDase contributed with ‘Mucosal proteases and their inhibitors in inflammatory bowel disease: from ethiopathological insight to innovative therapy’.
Fairmont Chateau Lake Louise, Canada
February 8-13, 2009
IBDase contributed with ‘Mucosal proteases and their inhibitors in inflammatory bowel disease: from ethiopathological insight to innovative therapy’.
Swiss RNA workshop 2009
January/2009/
Swiss RNA workshop
2009
University of Bern, Switzerland
January 30, 2009
A presentation titled ‘Mucosal proteases and their inhibitors in inflammatory bowel disease’ was given.
University of Bern, Switzerland
January 30, 2009
A presentation titled ‘Mucosal proteases and their inhibitors in inflammatory bowel disease’ was given.
Keystone Symposium: Innate, Adaptive and Regulatory Immune Responses to Intestinal Microbiota
January/2009/
Keystone Symposium: Innate, Adaptive and
Regulatory Immune Responses to Intestinal
Microbiota
Sagebrush Inn and Conference Center, Taos, New Mexico
January 13-18, 2009
A member of IBDase presented ‘Mucosal proteolysis in inflammatory bowel disease’.
Sagebrush Inn and Conference Center, Taos, New Mexico
January 13-18, 2009
A member of IBDase presented ‘Mucosal proteolysis in inflammatory bowel disease’.
Meeting of the European Mucosal Immunology Group
October/2008/
European Mucosal Immunology Group
(EMIG)
2008 Meeting
Milan, Italy
October 8-10, 2008
2008 Meeting
Milan, Italy
October 8-10, 2008
ESF conference: Functional Genomics and Disease
October/2008/
Functional Genomics and Disease
European Science Foundation Conference
Innsbruck, Austria
October 1-4, 2008
The presentation ‘Mucosal proteases and their inhibitors in inflammatory bowel disease: a systematic review’ was given by a consortium member.
European Science Foundation Conference
Innsbruck, Austria
October 1-4, 2008
The presentation ‘Mucosal proteases and their inhibitors in inflammatory bowel disease: a systematic review’ was given by a consortium member.
Gordon Research Conference "Proteases"
July/2008/
Gordon Research Conference
“Proteases”
Colby-Sawyer College , New London, NH, U.S.A.
July 6-11, 2008
IBDase contributed with a presentation titled ‘Mucosal proteases and their inhibitors in inflammatory bowel disease’.
Colby-Sawyer College , New London, NH, U.S.A.
July 6-11, 2008
IBDase contributed with a presentation titled ‘Mucosal proteases and their inhibitors in inflammatory bowel disease’.
Falk Symposium 164. Intestinal Disorders
May/2008/
Falk Symposium 164. Intestinal
Disorders
Budapest, Hungary
May 2-3, 2008
Budapest, Hungary
May 2-3, 2008